Readnour Robin Shane Insider Trades

Insider Trading History

Track insider trading activity for Readnour Robin Shane. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $0 0 shares
Last Trade
Mar 19, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$174k 44,466 shares
$3.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99k 23,742 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 44,466 shares
$3.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $85.1k 20,400 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2k 20,400 shares
$1.04
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $79.7k 19,111 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.7k 19,111 shares
$1.19
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $37.9k 9,077 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2k 9,077 shares
$1.34
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.72M 652,573 shares
Last Trade
Dec 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.45k 5,000 shares
$1.49
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.7M 647,573 shares
Last Trade
Dec 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4k 18,483 shares
$1.43
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.62M 629,090 shares
Last Trade
Dec 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.45k 6,517 shares
$1.45
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.6M 622,573 shares
Last Trade
Nov 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35.5k 25,000 shares
$1.42
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.49M 597,573 shares
Last Trade
Nov 26, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.4k 12,500 shares
$1.39
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.44M 585,073 shares
Last Trade
Nov 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$32.5k 25,000 shares
$1.30
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.34M 560,073 shares
Last Trade
Nov 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$77.3k 75,000 shares
$1.03
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $269k 64,503 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 64,503 shares
$2.00
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.02M 485,073 shares
Last Trade
Jan 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$31.2k 1,425 shares
$21.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.03M 485,792 shares
Last Trade
Jan 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$80.5k 3,669 shares
$21.93
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99k 23,742 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 23,742 shares
$5.91
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $86.4k 20,724 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 20,724 shares
$17.28
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $0 0 shares
Last Trade
Mar 29, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.08M 71,839 shares
$15.01
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $2.03M 487,592 shares
Last Trade
Mar 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.24M 82,618 shares
$15.00
$4.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up